| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-319-22822-8_14 |
| P698 | PubMed publication ID | 26424653 |
| P50 | author | Nancy Raab-Traub | Q90483481 |
| P2860 | cites work | Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms | Q70456616 |
| Localization of the Epstein-Barr virus protein LMP 1 to exosomes | Q45237056 | ||
| Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma | Q45605928 | ||
| Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease | Q45613226 | ||
| Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma | Q45665252 | ||
| Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia | Q45740958 | ||
| Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma | Q45743631 | ||
| The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex | Q45746529 | ||
| Sequence variation in the Epstein-Barr virus latent membrane protein 1. | Q45782895 | ||
| Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells | Q45796774 | ||
| DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative | Q45803144 | ||
| Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. | Q45820444 | ||
| Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies | Q45826327 | ||
| Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China | Q45827831 | ||
| Detection of Antigens Associated With Epstein-Barr Virus Replication in Extracts From Biopsy Specimens of Nasopharyngeal Carcinomas | Q45831879 | ||
| The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. | Q45835618 | ||
| Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases | Q45845223 | ||
| Detection and prevalence of the “f” variant of epstein-barr virus in Southern China | Q45862289 | ||
| EBV specific CTL: a model for immune therapy | Q45888825 | ||
| Clonal antigen receptor gene rearrangements and Epstein-Barr viral DNA in tissues of Hodgkin's disease | Q46254634 | ||
| EBV persistence in memory B cells in vivo. | Q52037383 | ||
| An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 | ||
| Salted fish and nasopharyngeal carcinoma in southern Chinese | Q66698677 | ||
| Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese | Q69599721 | ||
| Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas | Q70061763 | ||
| Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus | Q24524755 | ||
| An Epstein-Barr virus protein interacts with Notch | Q24529019 | ||
| Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis | Q24632165 | ||
| The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB | Q24646694 | ||
| An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival | Q24649032 | ||
| Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed | Q25257225 | ||
| A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia | Q27349177 | ||
| Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization | Q28243346 | ||
| Identification of virus-encoded microRNAs | Q28259309 | ||
| The enigmatic epidemiology of nasopharyngeal carcinoma | Q28268076 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9 | Q33265945 | ||
| Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies | Q33373662 | ||
| EBV gene expression in an NPC-related tumour. | Q33576708 | ||
| Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats | Q33649035 | ||
| Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing | Q33700293 | ||
| Epstein-Barr virus provides a survival factor to Burkitt's lymphomas | Q33716529 | ||
| Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant | Q33762569 | ||
| Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression | Q33786551 | ||
| Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway | Q33787396 | ||
| Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A | Q33794029 | ||
| A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus | Q33838266 | ||
| Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia | Q33891606 | ||
| miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis | Q34023389 | ||
| Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation | Q34029669 | ||
| Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes | Q34171808 | ||
| Human tumor virus utilizes exosomes for intercellular communication. | Q34377767 | ||
| A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas | Q34457976 | ||
| Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation | Q34485302 | ||
| Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma | Q34579494 | ||
| Efficient replication of Epstein-Barr virus in stratified epithelium in vitro | Q34581330 | ||
| Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro | Q34717880 | ||
| The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo | Q34973323 | ||
| Itchy, a Nedd4 Ubiquitin Ligase, Downregulates Latent Membrane Protein 2A Activity in B-Cell Signaling | Q34975783 | ||
| Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes | Q35080523 | ||
| Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence | Q35155351 | ||
| The role of miRNAs and EBV BARTs in NPC. | Q35924359 | ||
| The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. | Q35924384 | ||
| Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model. | Q35943724 | ||
| Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway | Q35948025 | ||
| Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression | Q36066487 | ||
| Unique signaling properties of CTAR1 in LMP1-mediated transformation | Q36098869 | ||
| Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies | Q36231550 | ||
| Modelling glandular epithelial cancers in three-dimensional cultures | Q36251934 | ||
| A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells | Q36263086 | ||
| Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation | Q36276627 | ||
| Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner | Q36324519 | ||
| Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice | Q36327458 | ||
| Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping | Q36390998 | ||
| Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells | Q36483613 | ||
| Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation | Q36559750 | ||
| Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. | Q36766875 | ||
| Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. | Q36890676 | ||
| Potential selection of LMP1 variants in nasopharyngeal carcinoma | Q36944141 | ||
| IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3 | Q36984994 | ||
| Modulation of B-cell exosome proteins by gamma herpesvirus infection | Q37068487 | ||
| Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells | Q37093324 | ||
| Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs | Q37336691 | ||
| Proof for EBV's sustaining role in Burkitt's lymphomas | Q37463625 | ||
| Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells | Q37547400 | ||
| Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site | Q37552683 | ||
| Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies | Q38294587 | ||
| Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 | ||
| Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping | Q38484975 | ||
| Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. | Q38610363 | ||
| Epstein-Barr virus nuclear antigen 1 replication and segregation functions in nasopharyngeal carcinoma cell lines | Q38748334 | ||
| Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study | Q39102898 | ||
| Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. | Q39123741 | ||
| Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma | Q39455578 | ||
| Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. | Q39585482 | ||
| Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta | Q39595269 | ||
| Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies | Q39666008 | ||
| Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay | Q39711736 | ||
| Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation | Q39904201 | ||
| Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma | Q39952661 | ||
| EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines. | Q40022307 | ||
| Replication of EBV in epithelial cells during infectious mononucleosis | Q40086221 | ||
| Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease | Q40129013 | ||
| Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern. | Q40275967 | ||
| Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells | Q40326039 | ||
| Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. | Q40399583 | ||
| Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation | Q40487971 | ||
| TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1. | Q40512215 | ||
| RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma | Q40577439 | ||
| Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway | Q40623366 | ||
| Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling | Q40687983 | ||
| EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness | Q40718647 | ||
| Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus | Q40934947 | ||
| Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains | Q40936386 | ||
| Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection | Q40967827 | ||
| Regulation of Epstein-Barr virus latency by latent membrane protein 2. | Q41125684 | ||
| Detection of Epstein-Barr Virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines | Q41244707 | ||
| The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation | Q43610021 | ||
| Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease | Q43936463 | ||
| Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma | Q43947306 | ||
| The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region | Q44081032 | ||
| Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese | Q44192526 | ||
| Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. | Q44833814 | ||
| P433 | issue | Pt 1 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 339-363 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus | |
| P478 | volume | 390 |
| Q57093338 | Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells |
| Q57093333 | Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma |
| Q90483485 | Alterations in cellular expression in EBV infected epithelial cell lines and tumors |
| Q90747148 | Analogies Between Cancer-Derived Extracellular Vesicles and Enveloped Viruses with an Emphasis on Human Breast Cancer |
| Q50045673 | C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes |
| Q90187382 | Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma |
| Q59360905 | Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma |
| Q33892295 | Dissecting the regulation of EBV's BART miRNAs in carcinomas |
| Q55362409 | Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma. |
| Q47259217 | EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma |
| Q57010907 | Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q64904294 | Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma. |
| Q52340925 | Exosomes in Nasopharyngeal Carcinoma. |
| Q99563092 | HNSCC: Tumour Antigens and Their Targeting by Immunotherapy |
| Q92125666 | Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection |
| Q38709621 | LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis |
| Q38694375 | Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis |
| Q52347943 | New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. |
| Q33743639 | Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer |
| Q40228185 | Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma |
| Q96304633 | Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma |
| Q92860015 | The Global Landscape of EBV-Associated Tumors |
| Q47408030 | The effect of Mepitel Film on acute radiation-induced skin reactions in head and neck cancer patients: a feasibility study |
| Q40046657 | Tumour viruses and innate immunity |
Search more.